blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2522746

EP2522746 - MicroRNA expression profile associated with pancreatic cancer [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.09.2015
Database last updated on 19.07.2024
Most recent event   Tooltip27.10.2017Lapse of the patent in a contracting state
New state(s): BE		published on 29.11.2017  [2017/48]
Applicant(s)For all designated states
The Ohio State University Research Foundation
1524 North High Street
Columbus, OH 43201-1063 / US
For all designated states
The Board of Regents of the University of Oklahoma
660 Parrington Oval
Norman, OK 73019 / US
[2013/30]
Former [2013/24]For all designated states
The Ohio State University Research Foundation
1524 North High Street
Columbus, OH 43201-1063 / US
For all designated states
Brackett, Daniel J.
2812 William Blvd.
Seminole, OK 74868 / US
Former [2012/46]For all designated states
The Ohio State University
1524 North High Street
Columbus, OH 43201 / US
Inventor(s)01 / Schmittgen, Thomas D.
93 Alberry Drive
Granville, OH 43023 / US
02 / Brackett, Daniel J.
2812 William Blvd.
Seminole, OK 74868 / US
 [2012/46]
Representative(s)Denison, Christopher Marcus, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2014/46]Denison, Christopher Marcus, et al
Mewburn Ellis LLP
33 Gutter Lane
London
EC2V 8AS / GB
Former [2012/46]Denison, Christopher Marcus, et al
Mewburn Ellis LLP
33 Gutter Lane
London Greater London EC2V 8AS / GB
Application number, filing date12168648.902.03.2007
[2012/46]
Priority number, dateUS20060778271P02.03.2006         Original published format: US 778271 P
[2012/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2522746
Date:14.11.2012
Language:EN
[2012/46]
Type: B1 Patent specification 
No.:EP2522746
Date:12.11.2014
Language:EN
[2014/46]
Search report(s)(Supplementary) European search report - dispatched on:EP17.10.2012
ClassificationIPC:C12Q1/68, C07H21/02
[2012/46]
CPC:
C12Q1/6886 (EP,US); C12Q1/686 (US); A61P1/18 (EP);
A61P35/00 (EP); A61P35/04 (EP); A61P43/00 (EP);
C12Q1/6813 (US); C12Q1/6869 (US); C12Q2600/136 (EP,US);
C12Q2600/178 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/46]
TitleGerman:Mikro-RNA-Expressionsprofil im Zusammenhang mit Bauchspeicheldrüsenkrebs[2012/46]
English:MicroRNA expression profile associated with pancreatic cancer[2012/46]
French:Profil d'expression de micro-ARN associé au cancer du pancréas[2012/46]
Examination procedure14.05.2013Examination requested  [2013/26]
18.06.2013Amendment by applicant (claims and/or description)
05.12.2013Communication of intention to grant the patent
20.05.2014Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
28.07.2014Fee for grant paid
28.07.2014Fee for publishing/printing paid
28.07.2014Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07757822.7  / EP1991706
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070757822) is  11.05.2010
Opposition(s)13.08.2015No opposition filed within time limit [2015/43]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
28.07.2014Request for further processing filed
28.07.2014Full payment received (date of receipt of payment)
Request granted
05.08.2014Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
18.06.2013Request for further processing filed
18.06.2013Full payment received (date of receipt of payment)
Request granted
27.06.2013Decision despatched
Fees paidRenewal fee
07.06.2012Renewal fee patent year 03
07.06.2012Renewal fee patent year 04
07.06.2012Renewal fee patent year 05
07.06.2012Renewal fee patent year 06
27.03.2013Renewal fee patent year 07
30.09.2014Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.03.201408   M06   Fee paid on   30.09.2014
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU02.03.2007
AT12.11.2014
BE12.11.2014
BG12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
MT12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
TR12.11.2014
GR13.02.2015
LU02.03.2015
IS12.03.2015
PT12.03.2015
CH31.03.2015
LI31.03.2015
[2017/46]
Former [2017/39]HU02.03.2007
AT12.11.2014
BG12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
MT12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
TR12.11.2014
GR13.02.2015
LU02.03.2015
IS12.03.2015
PT12.03.2015
CH31.03.2015
LI31.03.2015
Former [2017/03]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
MT12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
GR13.02.2015
LU02.03.2015
IS12.03.2015
PT12.03.2015
CH31.03.2015
LI31.03.2015
Former [2016/12]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SI12.11.2014
SK12.11.2014
GR13.02.2015
LU02.03.2015
IS12.03.2015
PT12.03.2015
CH31.03.2015
LI31.03.2015
Former [2016/06]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
GR13.02.2015
LU02.03.2015
IS12.03.2015
PT12.03.2015
CH31.03.2015
LI31.03.2015
Former [2016/03]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
IT12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
GR13.02.2015
LU02.03.2015
IS12.03.2015
PT12.03.2015
Former [2015/47]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
GR13.02.2015
LU02.03.2015
IS12.03.2015
PT12.03.2015
Former [2015/46]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
LT12.11.2014
LV12.11.2014
MC12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/37]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
SK12.11.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/36]AT12.11.2014
CY12.11.2014
CZ12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
RO12.11.2014
SE12.11.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/35]AT12.11.2014
CY12.11.2014
DK12.11.2014
EE12.11.2014
ES12.11.2014
FI12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/26]AT12.11.2014
CY12.11.2014
ES12.11.2014
FI12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/25]AT12.11.2014
ES12.11.2014
FI12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/24]ES12.11.2014
FI12.11.2014
LT12.11.2014
LV12.11.2014
NL12.11.2014
PL12.11.2014
SE12.11.2014
GR13.02.2015
IS12.03.2015
PT12.03.2015
Former [2015/23]ES12.11.2014
FI12.11.2014
LT12.11.2014
NL12.11.2014
IS12.03.2015
PT12.03.2015
Former [2015/22]LT12.11.2014
PT12.03.2015
Former [2015/20]LT12.11.2014
Documents cited:Search[X]WO2005078139  (UNIV JEFFERSON [US], et al) [X] 1-14 * see whole doc. esp. claims *;
 [E]WO2007081680  (UNIV OHIO STATE RES FOUND [US], et al) [E] 1-14 * see whole doc. esp. claims and Table 3 *;
 [I]  - JIANG JINMAI ET AL, "Real-time expression profiling of microRNA precursors in human cancer cell lines", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, GB, vol. 33, no. 17, doi:10.1093/NAR/GKI863, ISSN 1362-4962, (20050101), pages 5394 - 5403, (20050928), XP002489966 [I] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1093/nar/gki863
 [I]  - VOLINIA STEFANO ET AL, "A microRNA expression signature of human solid tumors defines cancer gene targets", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (20060214), vol. 103, no. 7, doi:10.1073/PNAS.0510565103, ISSN 0027-8424, pages 2257 - 2261, XP002460699 [I] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.0510565103
by applicantUS4235871
 US4501728
 US4837028
 US4920016
 US4987071
 US5019369
 EP0430402
 US5093246
 US5139941
 US5252479
 WO9324641
 WO9413788
 US5427916
 US5849902
 US6232068
 US2002086356
 US2002173478
 US2004014113
 US2004018176
 US2005277139
 US2006078924
    - FUKUSHIMA, N. ET AL., CANCER BIOL THER., (2003), vol. 2, pages 78 - 83
    - ROSTY, C. ET AL., HEMATOL ONCOL CLIN NORTH AM., (2002), vol. 16, pages 37 - 52
    - MATSUBAYASHI, H. ET AL., CLINICAL CANCER RESEARCH, (2005), vol. 11, pages 573 - 583
    - GRONBORG, M. ET AL., JOURNAL OF PROTEOME RESEARCH, (2004), vol. 3, no. 5, pages 1042 - 1055
    - HEID ET AL., "Real time quantitative PCR", GENOME RES., (1996), vol. 10, pages 986 - 994
    - GIBSON ET AL., "A novel method for real time quantitative RT-PCR", GENOME RES., (1996), vol. 10, pages 995 - 1001, XP000642796
    - JIANG, J. ET AL., NUCLEIC ACIDS RES., (2005), vol. 33, pages 5394 - 5403
    - SCHMITTGEN T. D. ET AL., NUCLEIC ACIDS RES., (2004), vol. 32, page E43
    - MA YJ ET AL., "RNase protection assay", METHODS, (1996), vol. 10, pages 273 - 8
    - GRIFFITHS-JONES, S., "The microRNA Registry", NUCLEIC ACIDS RES, (2004), vol. 32, no. 1, doi:doi:10.1093/nar/gkh023, pages D109 - 11, XP002392427

DOI:   http://dx.doi.org/10.1093/nar/gkh023
    - SAMBROOK ET AL., Molecular Cloning, A Laboratory Manual
    - ANGERER, METH. ENZYMOL., (1987), vol. 152, page 649
    - ALBERTSON, EMBO J., (1984), vol. 3, pages 1227 - 1234
    - PINKEL, PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, pages 9138 - 9142
    - Methods in Molecular Biology, Vol. 33: In Situ Hybridization Protocols, HUMANA PRESS, (1994), vol. 33
    - WU; WALLACE, GENOMICS, (1989), vol. 4, page 560
    - LANDEGREN ET AL., SCIENCE, (1988), vol. 241, page 1077
    - BARRINGER ET AL., GENE, (1990), vol. 89, page 117
    - KWOH ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, page 1173
    - GUATELLI ET AL., PROC NAT ACAD SCI, USA, (1990), vol. 87, page 1874
    - POLLACK ET AL., NAT. GENET., (1999), vol. 23, no. 1, pages 41 - 6
    - ZENG ET AL., MOLECULAR CELL, (2002), vol. 9, pages 1327 - 1333
    - TUSCHL, NAT. BIOTECHNOL, (2002), vol. 20, pages 446 - 448
    - BRUMMELKAMP ET AL., SCIENCE, (2002), vol. 296, pages 550 - 553
    - MIYAGISHI ET AL., NAT. BIOTECHNOL., (2002), vol. 20, pages 497 - 500
    - PADDISON ET AL., GENES DEV., (2002), vol. 16, pages 948 - 958
    - LEE ET AL., NAT. BIOTECHNOL., (2002), vol. 20, pages 500 - 505
    - PAUL ET AL., NAT. BIOTECHNOL., (2002), vol. 20, pages 505 - 508
    - RABINOWITZ, J.E. ET AL., J. VIROL., (2002), vol. 76, pages 791 - 801
    - DORNBURG, GENE THERAP., (1995), vol. 2, pages 301 - 310
    - EGLITIS, BIOTECHNIQUES, (1988), vol. 6, pages 608 - 614
    - MILLER, HUM. GENE THERAP., (1990), vol. 1, pages 5 - 14
    - ANDERSON, NATURE, (1998), vol. 392, pages 25 - 30
    - XIA ET AL., NAT. BIOTECH., (2002), vol. 20, pages 1006 - 1010
    - SAMULSKI ET AL., J. VIROL., (1987), vol. 61, pages 3096 - 3101
    - FISHER ET AL., J. VIROL., (1996), vol. 70, pages 520 - 532
    - SAMULSKI ET AL., J. VIROL., (1989), vol. 63, pages 3822 - 3826
    - JONES PA; BAYLIN SB, "The fundamental role of epigenetic events in cancer", NAT REV GENET., (2005), vol. 3, pages 415 - 28, XP008042555
    - KRUTZFELDT J ET AL., "Silencing of microRNAs in vivo with 'antagomirs", NATURE, (2005), vol. 438, no. 7068, pages 685 - 9
    - RYLOVA ET AL., CANCER RES, (2002), vol. 62, no. 3, pages 801 - 8
    - SHIM ET AL., INT. J. CANCER, (2001), vol. 94, no. 1, pages 6 - 15
    - MISCHIATI ET AL., INT. J. MOL. MED., (2002), vol. 9, no. 6, pages 633 - 9
    - MORISHITA ET AL., ANN. N Y ACAD. SCI., (2001), vol. 947, pages 294 - 301
    - ANDRATSCHKE ET AL., ANTICANCER RES, (2001), vol. 21, no. 5, pages 3541 - 3550
    - STEIN; CHENG, SCIENCE, (1993), vol. 261, page 1004
    - ROSSI, CURRENT BIOLOGY, (1994), vol. 4, pages 469 - 471
    - WERNER; UHLENBECK, NUCL. ACIDS RES., (1995), vol. 23, pages 2092 - 96
    - HAMMANN ET AL., ANTISENSE AND NUCLEIC ACID DRUG DEV., (1999), vol. 9, pages 25 - 31
    - SZOKA ET AL., ANN. REV. BIOPHYS. BIOENG., (1980), vol. 9, page 467
    - GABIZON ET AL., PROC. NATL. ACAD. SCI., U.S.A., (1988), vol. 18, pages 6949 - 53
    - JIANG, J. ET AL., NUCLEIC ACIDS RES, (2005), vol. 33, pages 5394 - 5403
    - SCHMITTGEN T. D. ET AL., NUCLEIC ACIDS RES, (2004), vol. 32, page E43
    - LEE ET AL., INT. J. CANCER, (2006), vol. 120, pages 1046 - 1054
    - IMBEAUD, S. ET AL., NUCLEIC ACIDS RES, (2005), vol. 33, page E56
    - EISEN MB ET AL., PROC NATL ACAD SCI USA, (1998), vol. 95, pages 14863 - 8
    - SAEED AI ET AL., BIOTECHNIQUES, (2003), vol. 34, pages 374 - 8
    - KIM ET AL., SCIENCE, (2001), vol. 293, pages 2087 - 92
    - TIBSHIRANI R ET AL., PROC NATL ACAD SCI USA, (2002), vol. 99, pages 6567 - 72
    - RUBIE C ET AL., MOL CELL PROBES, (2005), vol. 19, pages 101 - 9
    - POY MN ET AL., NATURE, (2004), vol. 432, pages 226 - 30
    - LAU NC ET AL., SCIENCE, (2001), vol. 294, pages 858 - 62
    - SCHMITTGEN TD ET AL., NUCLEIC ACIDS RES, (2004), vol. 32, page E43
    - CHEN, C. ET AL., NUCLEIC ACIDS RES, (2005), vol. 33, page E179
    - POY M. N. ET AL., NATURE, (2004), vol. 432, pages 226 - 30
    - NUOVO GJ ET AL., PROC NATL ACAD SCI USA, (1999), vol. 96, pages 12754 - 9
 US20050656109
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.